Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 2Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Drug-drug Interaction,SHR3680 1

Interventions

pembrolizumab 67Cyclophosphamide 45Cisplatin 45Nivolumab 39Paclitaxel 35Carboplatin 31Radiotherapy 30Gemcitabine 28Docetaxel 27Dexamethasone 23atezolizumab 22Bevacizumab 20Doxorubicin 19Vincristine 17Magnetic Resonance Spectroscopy 17Lenalidomide 17fludarabine 16Radiosurgery 16Fluorouracil 16Etoposide 16Blood Specimen Collection 16Rituximab 15Radiation 15Letrozole 15Irinotecan 15Ipilimumab 15palbociclib 14Leucovorin 14Cytarabine 14Surveys and Questionnaires 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Rosuvastatin Calcium × 90 days × Clear all
NCT04621669 2026-06-05

Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
36 enrolled

Drug-drug Interaction,SHR3680

Data powered by HemOnc (CC BY 4.0) Colophon âš¡